Status:
COMPLETED
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Hepatitis
Liver Cirrhosis
Eligibility:
All Genders
30-80 years
Brief Summary
BACKGROUND The insulin-like growth factor system (IGFs) plays an important role in cell growth and differentiation. Nevertheless, the roles played by insulin-like growth factor-1 (IGF-1), insulin-like...
Detailed Description
healthy controls:one blood sample (7.5 cc) hepatitis: three blood samples, at admission, at 3rd and 7-10th day of admission liver cirrhosis: two blood samples, at 1-2 years interval (7.5 cc/each sessi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Hepatocellular carcinoma
- Must be primary Hepatocellular carcinoma and untreament
Exclusion
- treatment Hepatocellular carcinoma
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00679692
Start Date
September 1 2006
End Date
March 1 2008
Last Update
May 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Radio immunoassay lab,Department of Nuclear Medical University Hospital,No.100 Tzyou 1st Road
Kaohsiung City, Taiwan